Ray Dalio
WST icon

Ray Dalio’s West Pharmaceutical WST Stock Holding History

Ray Dalio’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.81M Buy
23,161
+19,088
+469% +$4.75M 0.03% 389
2025
Q4 		$1.12M Buy
+4,073
New +$1.11M ﹤0.01% 867
2024
Q2 		– Sell
-1,292
Closed -$511K – 945
2024
Q1 		$511K Sell
1,292
-3,101
-71% -$1.15M ﹤0.01% 621
2023
Q4 		$1.55M Sell
4,393
-262
-6% -$92.7K 0.01% 568
2023
Q3 		$1.75M Sell
4,655
-280
-6% -$108K 0.01% 517
2023
Q2 		$1.89M Sell
4,935
-30
-0.6% -$10.7K 0.01% 469
2023
Q1 		$1.72M Sell
4,965
-7,254
-59% -$2.12M 0.01% 485
2022
Q4 		$2.88M Sell
12,219
-29,858
-71% -$7.08M 0.02% 466
2022
Q3 		$10.4M Buy
42,077
+18,921
+82% +$5.76M 0.05% 248
2022
Q2 		$7M Buy
23,156
+12,266
+113% +$3.99M 0.03% 411
2022
Q1 		$4.47M Buy
10,890
+2,525
+30% +$988K 0.02% 496
2021
Q4 		$3.92M Sell
8,365
-75,708
-90% -$32.6M 0.02% 349
2021
Q3 		$35.7M Sell
84,073
-3,495
-4% -$1.47M 0.2% 96
2021
Q2 		$31.4M Buy
87,568
+39,073
+81% +$12.9M 0.2% 90
2021
Q1 		$13.7M Buy
48,495
+6,132
+14% +$1.75M 0.12% 132
2020
Q4 		$12M Buy
42,363
+24,718
+140% +$6.94M 0.1% 108
2020
Q3 		$4.85M Buy
+17,645
New +$4.67M 0.06% 142

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ray Dalio's WST Position: Q1 2026 in Review

Ray Dalio increased its West Pharmaceutical (WST) stake by 469% in Q1 2026, buying an estimated $4.75M and bringing the position to 23,161 shares worth $5.81M. The position accounts for 0.03% of the portfolio, ranked #389.

Ray Dalio first reported a position in WST in Q3 2020 and has held it in 17 quarters since. The position peaked at $35.7M in Q3 2021. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Ray Dalio held 23,161 shares of West Pharmaceutical worth $5.81M as of Q1 2026.
  • Ray Dalio bought 19,088 West Pharmaceutical shares in Q1 2026, an estimated $4.75M.
  • West Pharmaceutical made up 0.03% of Ray Dalio's portfolio in Q1 2026, its #389 holding.
  • Ray Dalio first reported a position in West Pharmaceutical in Q3 2020 and has held it in 17 quarters since.
  • Ray Dalio's West Pharmaceutical position peaked at $35.7M in Q3 2021.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.